NCT03522688View on ClinicalTrials.gov

Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation

PHASE4UnknownINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

July 14, 2023

Study Completion Date

July 7, 2024

Conditions
Acute Kidney InjuryLiver Diseases
Interventions
DRUG

Dexmedetomidine

The treatment group was given dexmedetomidine by constant intravenous (IV) infusion at a rate of 0.4mcg/kg/hour.

DRUG

Normal saline

The control group was given normal saline by constant intravenous (IV) infusion at a rate of 0.4mcg/kg/hour

Trial Locations (1)

05505

Asan medical center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER